基础医学与临床 ›› 2010, Vol. 30 ›› Issue (4): 434-436.

• 短篇综述 • 上一篇    下一篇

P2嘌呤受体亚型与冠心病的关系

聂永莉 张玉芹   

  1. 武汉科技大学医学院 武汉科技大学医学院
  • 收稿日期:2009-02-17 修回日期:2009-06-05 出版日期:2010-04-05 发布日期:2010-04-05
  • 通讯作者: 张玉芹

Relation between P2 purinoceptor subtypes and

Yong-li NIE, Yu-qin ZHANG   

  1. Medical College,Wuhan University of Science and Technology Medical College,Wuhan University of Science and Technology
  • Received:2009-02-17 Revised:2009-06-05 Online:2010-04-05 Published:2010-04-05
  • Contact: Yu-qin ZHANG

摘要: 嘌呤受体包括P1受体和P2受体。本文综述了P2嘌呤受体的多个亚型与冠心病之间的关系,P2Y1、P2Y2、P2Y11和P2X7受体参与动脉粥样硬化斑块中的炎症反应,P2X3受体参与了心绞痛的伤害性反应,P2X4受体参与血管重塑和增强非梗死区心肌的收缩力,P2Y2和P2Y6与冠脉介入术后再狭窄的形成有关,P2Y11受体的多态性可增加心肌梗死的风险,P2Y1、P2Y12和P2X1受体则参与了血栓的形成。研制P2嘌呤受体各亚型特异性的激动剂和拮抗剂对开发治疗冠心病的新药具有重要意义。

Abstract: In this article we review the relation between P2 purinoceptor subtypes and coronary heart disease (CHD). P2Y1、P2Y2、P2Y11 and P2X7 receptors relate to inflammatory reaction in atherosclerosis plaque. P2X3 receptor plays an important role in anginal nocuity response. P2X4 receptor involve in vascular remodeling and enhancement of myocardial contractility in non-infarct zone. P2Y2 and P2Y6 receptors involve in restenosis. A polymorphism in P2Y11 receptors adds the risk of myocardial infarction. P2Y1、P2Y12 and P2X1 receptors participate to thrombotic formation. The specific agonist and antagonist of P2 purinoceptor subtypes could be potential targets for new drugs of CHD.